Moderna, Inc. — Ethics Grade C-

Moderna, Inc. receives an overall ethics grade of C- (42/100) on CancelCo's corporate accountability database. Sector: Healthcare. Market cap: Large Cap.

Category scores

• labor: 60
• privacy: 80
• consumer: 35
• environment: 65
• humanRights: 25

Documented incidents (3)

• Vaccine Equity Failure (high, 2021) — Faced intense criticism for primarily supplying wealthy nations with COVID-19 vaccines while ignoring requests from low-income countries.
• Vaccine Price Gouging Plans (high, 2023) — Announced plans to quadruple the price of COVID-19 vaccines to $110-$130 even though the technology was heavily funded by US taxpayers.
• Patent Infringement Defense (medium, 2022) — Involved in a messy legal battle with the NIH over refusal to credit government scientists as co-inventors on core mRNA patents.

Documented good deeds

• Kenya Manufacturing Site — Established a commitment to build a state-of-the-art mRNA manufacturing facility in Kenya to bolster regional vaccine production.

Ethical alternatives

• BioNTech SE — Better record of tech transfer to developing nations through 'BioNTainer' initiatives.